Orphan designation: daratumumab Treatment of plasma-cell myeloma, 17/07/2013 Expired | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 4 June 2026 - 14:20

Orphan designation: daratumumab Treatment of plasma-cell myeloma, 17/07/2013 Expired

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-13-1153

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters